Cormorant Asset Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-140,000
| Closed | -$23.7M | – | 57 |
|
|
2023
Q3 | $23.7M | Buy |
140,000
+60,000
| +75% | +$10.1M | 1.38% | 19 |
|
|
2023
Q2 | $17.3M | Hold |
80,000
| – | – | 0.97% | 26 |
|
|
2023
Q1 | $14.5M | Sell |
80,000
-30,000
| -27% | -$5.45M | 0.96% | 30 |
|
|
2022
Q4 | $21.6M | Sell |
110,000
-40,000
| -27% | -$7.86M | 1.45% | 25 |
|
|
2022
Q3 | $33.7M | Buy |
150,000
+25,000
| +20% | +$5.62M | 2.36% | 13 |
|
|
2022
Q2 | $15.8M | Sell |
125,000
-25,000
| -17% | -$3.16M | 1.2% | 25 |
|
|
2022
Q1 | $19M | Buy |
+150,000
| New | +$19M | 1.46% | 20 |
|